Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1022488

Platelet Counts and Risk of Major Bleeding With Ibrutinib


Lucijanic, Marko; Skelin, Marko
Platelet Counts and Risk of Major Bleeding With Ibrutinib // Clinical Lymphoma Myeloma and Leukemia, 19 (2019), 7; e399-e399 doi:10.1016/j.clml.2019.04.001 (međunarodna recenzija, pismo uredniku, znanstveni)


CROSBI ID: 1022488 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Platelet Counts and Risk of Major Bleeding With Ibrutinib

Autori
Lucijanic, Marko ; Skelin, Marko

Izvornik
Clinical Lymphoma Myeloma and Leukemia (2152-2650) 19 (2019), 7; E399-e399

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni

Ključne riječi
Ibrutinib ; Platelet Counts

Sažetak
Recently published study raised serious concerns regarding major bleeding risk, particularly among patients that were excluded from the population of trials which are the cornerstone of the ibrutinib use today due to need for concomitant therapies. In this letter to the editor we have addressed the issues of assessment of other factors associated with bleeding risk in order to ensure proper risk evaluation.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Opća bolnica Šibenik

Profili:

Avatar Url Marko Skelin (autor)

Avatar Url Marko Lucijanić (autor)

Citiraj ovu publikaciju

Lucijanic, Marko; Skelin, Marko
Platelet Counts and Risk of Major Bleeding With Ibrutinib // Clinical Lymphoma Myeloma and Leukemia, 19 (2019), 7; e399-e399 doi:10.1016/j.clml.2019.04.001 (međunarodna recenzija, pismo uredniku, znanstveni)
Lucijanic, M. & Skelin, M. (2019) Platelet Counts and Risk of Major Bleeding With Ibrutinib. Clinical Lymphoma Myeloma and Leukemia, 19 (7), e399-e399 doi:10.1016/j.clml.2019.04.001.
@article{article, year = {2019}, pages = {e399-e399}, DOI = {10.1016/j.clml.2019.04.001}, keywords = {Ibrutinib, Platelet Counts}, journal = {Clinical Lymphoma Myeloma and Leukemia}, doi = {10.1016/j.clml.2019.04.001}, volume = {19}, number = {7}, issn = {2152-2650}, title = {Platelet Counts and Risk of Major Bleeding With Ibrutinib}, keyword = {Ibrutinib, Platelet Counts} }
@article{article, year = {2019}, pages = {e399-e399}, DOI = {10.1016/j.clml.2019.04.001}, keywords = {Ibrutinib, Platelet Counts}, journal = {Clinical Lymphoma Myeloma and Leukemia}, doi = {10.1016/j.clml.2019.04.001}, volume = {19}, number = {7}, issn = {2152-2650}, title = {Platelet Counts and Risk of Major Bleeding With Ibrutinib}, keyword = {Ibrutinib, Platelet Counts} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font